Cardiol Therapeutics to Participate in B. Riley Securities Summit

Key Highlights

• Cardiol Therapeutics will participate in a Fireside Chat at the B. Riley Securities Mind, Muscle & Vision Summit.
• The event is scheduled for Thursday, July 16, 2026, at 12:20 p.m. EDT.
• The Fireside Chat will take place at the InterContinental Boston Hotel, in Abigail Adams Salon B.
• Cardiol Therapeutics is a late-stage life sciences company developing anti-inflammatory and anti-fibrotic therapies for heart disease.
• Its lead drug candidate, CardiolRx™, is being evaluated for recurrent pericarditis (MAVERIC Program) and acute myocarditis (ARCHER Program).
• The company is also developing CRD-38, a novel subcutaneously administered drug for inflammatory heart disease.